ANVS — ANNOVIS BIO INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ANNOVIS BIO INC (ANVS)
ANNOVIS BIO INC (ANVS) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $712,414. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ANVS
How many top investors track ANVS
Only 1 tracked investor report this position.
ANVS Ownership Composition
How ANNOVIS BIO INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting ANVS
- Ken GriffinMar 31, 2026Citadel AdvisorsShares104.9KValue$233.9K% Portfolio0.00%
Recent activity
- New$233.9KMay 15, 2026
- New$666.8KNov 14, 2025
Frequently asked questions
- How many institutional investors hold ANVS?
- 1 tracked institutional investor disclosed a position in ANVS (ANNOVIS BIO INC) in their most recent 13F filing.
- Who is the largest institutional holder of ANVS?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ANVS, valued at $712,414.
- Did institutional ownership of ANVS increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited ANVS.
- Where does this ANVS ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.